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Guided transfer of critically ill patients: where patients are
transferred can be an informed choice
Theodore J. Iwashynaa,b and Anthony J. Coureya
Introduction
The role of interhospital transfer in the critically ill
patient remains ill-defined. For a handful of conditions,
we have gold-standard evidence that prompt transfer of
patients offers real benefits. But for most of our patients,
things are less clear. Most research about patient transfers
answers three questions:
(1) Which patients should be transferred?
(2) How should we transfer them?
(3) Does transfer improve outcomes?
In this review we argue that one cannot answer questions
(1) and (3) unless we first answer a unique question –
where should we transfer patients? An answer to such a
question requires careful analysis of our actual transfer
practices, and necessitates acknowledging certain politic-
ally uncomfortable realities about differences among
hospitals. But, we will argue, doing so opens up the
possibility of a new approach – that we term guided
transfer – that seems likely to offer substantial improve-
ments in our patients’ outcomes.
This review will be organized as follows. First, we will
review foundational data, arguing that we now have a
system that can competently transfer patients over large
distances with few complications. Second, we identify a
core problem in current practice – the failure to recog-
nize that where one sends a patient is a choice, with
consequences that must be faced. Third, we present a
recently developed paradigm using high quality objec-
tive data on hospitals that can be used to guide transfer
decisions.We then suggest a strategy of guided transfer –
being selective not only about which patients are trans-
ferred, but where they are transferred – as an approach to
improving patient outcomes, including survival. Finally,
we discuss the evidence for such a strategy, as well as
approaches to implementing such a strategy on the
ground.
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Purpose of review
Given increasingly scarce healthcare resources and highly differentiated hospitals, with
growing demand for critical care, interhospital transfer is an essential part of the care of
many patients. The purpose of this review is to examine the extent to which hospital
quality is considered when transferring critically ill patients, and to examine the potential
benefits to patients of a strategy that incorporates objective quality data into referral
patterns.
Recent findings
Interhospital transfer of critically ill patients is now common and safe. Although extensive
research has focused on which patients should be transferred and when they should be
transferred, recent study has focused on where patients should be transferred. Yet, the
choice of destination hospital is rarely recognized as a therapeutic choice with
implications for patient outcomes. The recent public release of high-quality, risk-
adjusted and reliability-adjusted outcome data for most hospitals now offers physicians
an informed basis on which to choose to which destination hospital a patient should be
transferred. A strategy of ‘guided transfer’ that integrates public quality information into
critical care transfer decisions is now feasible.
Summary
Although hospitals often transfer patients, there may be substantial room for
improvement in transfer patterns. Guiding transfers on the basis of objective quality
information may offer substantial benefits to patients, and could be incorporated into
quality improvement initiatives.
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The foundation: interhospital transfer of
critically ill patients is now safe, common, and
often evidence-based
In the developed world, the interhospital transfer of
critically ill patients is now a routine practice both from
Emergency Departments and among hospitalized
patients [1–5,6!,7]. These transfers weave together a
multitiered system allowing patients to present to local
hospitals and then obtain access to specialized care in
other centers. Median transfer distances in the U.S. were
greater than 25 miles for critically ill patients, and trans-
fers greater than 50 miles were common [5,8!]. Given the
realities of limited resources and limited providers, not all
hospitals can provide access to every possible diagnostic
and interventional modality. As such, interhospital trans-
fer may occur for half or more of patients with certain
conditions [8!,9,10].
Interhospital transfer of patients was once quite danger-
ous. An important early review of adverse clinical events
during pediatric transfer during 1992 reported that 75% of
children experienced an adverse clinical event, and 23%
were deemed life-threatening [11]. This contrasts with
more recent data showing very low levels of adverse
events. For example, a review of Ontario’s centralized
transfer service showed that 981 (5.1%) of 19 228 urgent
aeromedical transfers involved an adverse event [12].
(The median transfer distance in this series was
10.5 km, but with frequent long range transfers.) Similarly
low rates have been observed in a number of other
contexts, ranging from careful studies of high acuity
transfers at a single center to system-wide audits
[6!,13–15]. We must acknowledge that an alternative
explanation for these data is that transfer services have
simply become much better at selecting which patients
can tolerate interhospital transfer; certainly patient selec-
tion can be an important source of bias in many transfer
studies [16!!]. But given the high acuity of many patients
transferred to referral centers, it seems likely that the
proliferation of guidelines for interhospital transfer
represents a real accumulation of knowledge about
how to safely perform this essential task [17–22].
With the increasing safety of interhospital transfer, there
is good evidence that for some conditions, prompt trans-
fer to an appropriate facility is clearly indicated. Prompt
interhospital transfer for percutaneous coronary interven-
tion results in better outcomes than thrombolysis when
prompt transfer is feasible for patients with ST-elevation
myocardial infarction (MI) – assuming such treatment is
done sufficiently quickly [23,24]. There are even some
data for high-risk non-ST elevation MI [25]. There are
excellent observational data on the benefits of transfer to
a trauma center for severely injured trauma patients
[26–28]. Stroke centers appear to have superior outcomes
[29!], via mechanisms other than simply faster times to
thrombolysis, although we await conclusive data on the
benefits of transfer to stroke centers.
The problem: destination is rarely recognized
as a therapeutic choice
Despite this growing evidence that interhospital transfer
can be thought of as a routine part of the medical
armamentarium, recent evidence shows that current prac-
tice rarely achieves for patients the full potential benefits.
In interviews with clinicians at several community hos-
pitals, practitioners discussed candidly their decision-
making process for patient transfers and destination
selection. In the many hours of tapes, there was no
discussion of relative quality of various alternative hos-
pitals as a determinant for transfer [30!]. Clinicians did
not perceive themselves to be choosing which destination
hospital, but rather only making a choice between trans-
ferring or keeping the patient. If more than one hospital
was considered, the discussion was driven by timely
acceptance, not the relative merits of different hospitals.
In these intensively studied hospitals, transfer destina-
tion can be understood as an organizational routine, that
is, something that is automatically performed, without
careful weighing of the relative benefits and risks of the
choices. Supporting this qualitative data are quantitative
data showing the remarkable stability of hospital transfer
relationships over time periods as long as a decade [31].
Quantitative and qualitative data from Italy likewise
suggest that transfer patterns there result primarily from
interhospital relationships, not efforts to optimize the
care of individual patients [32!!].
This leads to inefficiencies in hospital transfer decisions
that have real consequences for patients. Consider the
case of Medicare patients with acute myocardial infarc-
tion (AMI) being transferred from hospitals lacking
revascularization capabilities to hospitals that can per-
form revascularization. Forty-four percent of patients
with AMI admitted to nonrevascularization hospitals
undergo such a transfer [8!]. Yet 27% of such transferred
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Key points
! Interhospital transfers are common and safe.
! Existing transfer patterns do not fully direct
patients to the local hospitals with lowest 30-day
mortality.
! High quality public data on hospital outcomes are
now available.
! A strategy of guided transfer that takes into account
public outcome data may improve patient out-
comes.
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patients were transferred to a hospital with demonstrably
and clinically significantly worse outcomes that was also
farther away than another nearby option. In another
study, hospitals varied widely in the timeliness with
which they arranged transfers, but the characteristics of
hospitals that predicted greater timeliness did not predict
transfers to hospitals with better 30-day mortality [33!].
Thus, convergent data from a number of settings suggest
that when patients are transferred to another hospital,
little conscious thought goes into selecting the hospital by
quality of outcomes. Certainly, attention is paid to which
perceived class of hospital should be selected, but despite
wide variation in hospitals – and the fact that, at least in
the U.S., many hospitals within a given class are often
within feasible transfer range [5,8!] – little attention is
paid to optimizing hospital choice by outcomes data.
The opportunity: not all hospitals are the
same – and the data are public
It is possible to suggest that differentiating among hos-
pitals might be a simple matter of the hospital’s nominal
level of capacity. For example, it might be that there are
no important differences among hospitals performing
coronary artery bypass grafting, or offering critical care.
Yet such an argument is demonstrably false by ubiquitous
professional experience and large quantitative databases.
The data proving variation in quality – however con-
ceived – are overwhelming. In domains relevant to
critical care, this includes differences in risk-adjusted
and reliability-adjusted mortality for AMI, pneumonia
[34!!,35], and major surgery [36], and difference in pro-
cess measures ranging from curative therapies [37] to
‘end-of-life’ care in those over 65 years old [38]. This
accords with many physicians’ experience of calling
consults, and having the usefulness of the consult vary
substantially within a given service, depending on which
colleague happens to be available to take consults on a
given day. Just as not all physicians with the same
specialty certification are equally excellent, not all hos-
pitals with the same nominal resources achieve the same
patient outcomes.
Documenting variation in hospital quality alone might
not be of any value unless information on individual
hospital quality were available to providers forced to
make real-time decisions. In fact, condition-specific, high
quality, public data on most hospitals are now routinely
available in the U.S. through, for example, Hospital-
Compare (http://www.hospitalcompare.hhs.gov/). Care-
ful reviews have been published elsewhere that des-
cribe the important advances in risk-adjustment and
reliability-adjustment that make possible such data
[39,40,41!!,42,43] . As we discuss below, although these
metrics may not be perfect, they likely have advanced to
the point that their incorporation into clinical decision-
making would benefit patients. Yet given the reality of
the current decision-making process – often an uncon-
sidered routine – it is perhaps not surprising that these
high-quality data have had little clear impact on behavior
to date [44].
A proposal: improving patient outcomes by
guiding transfers
If our current habits often lead us to transfer patients to
inferior hospitals, and if superior, accessible hospitals can
be identified using existing data, then this suggests a
strategy for improving care using existing resources:
guiding transfers by objective publicly available quality
data may lead to improved patient outcomes.
This ‘guided transfer’ proposal can be thought of as the
next generation of selective referral. The Leapfrog
Group has long advocated that patients should be selec-
tively referred to hospitals with certain characteristics:
high volumes of relevant procedures, and intensivists
[45]. Similarly, there are compelling data on the advan-
tages and feasibility of referring trauma patients to ‘Level
1’ trauma centers [26,27,46]. But such recommendations
were loath to draw distinctions among hospitals with a
given class of resources. More recent data suggest that
guiding transfers, not just to any hospital of a given class,
but to the hospital with the best reported outcomes, will
offer further advantages.
To examine the potential importance of this approach,
consider again the case of transfers of AMI patients from
nonrevascularization hospitals to revascularization hospi-
tals. We carried out simulations in which a patient was
transferred to a hospital with the best reported 30-day
mortality ratings within a given radius [8!]. We then
examined the potential impact on patient outcomes,
taking into account the fact that the reported 30-day
mortality ratings had substantial uncertainty, and so
might be inaccurate in any given case. In such a situation,
transferring patients to the best hospital within 50 miles
reduced relative mortality by 11.9% [95% confidence
interval (CI): 11.7–12.1%], and reduced absolute
30-day mortality by 1.9% (95% CI: 1.9–2.0%). This
implies a number needed to treat of 53 patients to save
one life at 30-days, which compares quite favorably with
many standard-of-care interventions in cardiology [47].
In sum, these publicly reported 30-day mortality rates,
if carefully risk-adjusted and reliability-adjusted, can
serve as markers for higher quality hospitals.
How could ‘guided transfer’ be implemented?
The core contention of guided transfer is that physicians
should recognize that the particular choice of destination
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hospital is a choice of which therapy to provide a given
patient. This therapeutic option should be applied with
the same patient-centered commitment to excellence
used in choosing any other highly consequential therapy.
As in other cases, risk, benefit, and availability all need to
be considered.
Before discussing implementation, we must frankly
acknowledge that there is no gold-standard evidence
demonstrating that guided transfer improves outcomes.
Large-scale evaluation with careful attention to unin-
tended consequences has not yet been done.
There are four levels at which guided transfer can be
implemented, as described in Table 1. Physicians can
simply recognize that they have a choice in where they
send patients, and consciously attempt to optimize that
choice for individual patients. But they could also begin
to routinely incorporate up-to-date objective data in their
recommendations for patients. Several national data
sources exist in which carefully risk-adjusted and
reliability-adjusted data are published and updated
(examples are listed in Table 2 [35,36,43,48,49]). The
United States Department of Veterans Affairs (VA) has
been a national leader in developing methods for careful
and fair risk-adjustment and reliability-adjustment, and
broad-ranging data are available at http:// www.hospital
compare.va.gov/. It must be noted that these public
reporting systems were all designed in a political environ-
ment that made it difficult to report quantitative hospital
outcomes. As such, the default is to report a dichotomous
outcome, whether a hospital is probably better than the
national average or not. (This is akin to a lab reporting
whether a creatinine value is ‘normal’ or ‘abnormal’ rather
than giving the actual value.) Yet all websites have
‘details’ tabs that allow careful quantitative assessment
to allow nuanced clinical decision-making.
Unfortunately, the high quality outcomes data that are
needed for guided transfer are not routinely available for
some important conditions cared for by critical care physi-
cians. As of 2011, these conditions include severe sepsis,
acute respiratory distress syndrome, and acute exacer-
bation of chronic obstructive pulmonary disease. Devel-
oping methods and data infrastructure to support accurate
and fair reporting should be an important research priority.
There are important examples where the data infrastruc-
ture to support public reporting also drives ongoing quality
improvement efforts, including the VA’s success with the
Inpatient Evaluation Center [50!] and the many hospitals
that pay for the rich data of the APACHE system.
When condition-specific data are not available, clinicians
are forced to extrapolate – a situation with which they are
already routinely familiar in applying randomized con-
trolled trials to their own patients. Common clinical
examples include the use of thrombolytic therapy for
acute pulmonary embolism, the use of recombinant acti-
vated protein C for pneumonia, or the benefit of early
tracheostomy in the critically ill. In each of these common
scenarios, the literature can only make suggestions to the
clinician in the use of these therapies which might
dramatically alter patient outcome. Likewise, clinicians
should consider individually the decision regarding
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Table 1 Stages of guided transfer
Stage Description of behavior
1: Contemplative Recognize that where a patient is transferred is a choice of which therapy a patient will receive, and use
available information to make optimal choice for that patient
2: Individual Routinely seek out objective rigorous data on condition-specific outcomes, and use that to guide transfers
to hospital with best outcome data for a given condition
3: Systematic Develop quality improvement system in hospital to routinely monitor where and when transfers are sent,
and concordance of that practice with best available, updated data on outcomes at destination hospitals
4: Supported decision-making Develop integrated decision-support tools to rapidly identify patients who might benefit from transfer,
and provide individualized data on alternative transfer options
Table 2 Outcomes data for guided transfer
Condition Data source Comments
Acute myocardial infarction HospitalCompare for 30-day mortalitya Perhaps the best-described and validated measure
[35,43,48]
Pneumonia HospitalCompare for 30-day mortality
Congestive heart failure HospitalCompare for 30-day readmission Methods and validation have been published [49]
Surgeries Leapfrog evidence-based survival predictor Soon to be released [36]
Patients with the U.S. Veterans
Health Administration
VA HospitalCompare 30-day mortality http:// www.hospitalcompare.va.gov/
a To access the risk-adjusted death rates: first, go to http://www.hospitalcompare.hhs.gov; second, select nearby hospitals that are likely to be of high
quality based on what you know of them; third, click the ‘Compare’ button’; fourth, go to the ‘Outcome of Care Measures’ tab; fifth, click ‘View Tables’;
and finally click on the link to ‘Click here to view more information about individual hospital’s death (mortality) rates’. This will bring up a table with the
actual numbers that can be used to guide decisions.
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interfacility transfers according to safety, timing, location,
and potential risks and benefits. One might plainly con-
sider the scenario in which a provider’s own family may
need specialized medical care, i.e., ‘it’s what I would do
for my own family’.
There are a number of other potential barriers to guided
transfer, outlined in Table 3 [8!,30!,51!,52–58]. Some of
these are relevant to individual clinical decision-making,
whereas others are challenges to system-level imple-
mentation. One such system-level challenge is the fear
that widespread implementation of guided transfer
would overwhelm the best hospitals in a region. This
concern is fueled by anecdotes of ‘locked-in’ ICUs
unable to accept additional patients, which clearly occurs,
although we lack good data on how commonly. But those
same hospitals often also supply anecdotes of frequent
low-risk admissions to the ICU, and of the inability to
transfer patients out of the ICU to a floor bed after they
are no longer critically ill. Widespread implementation of
guided transfer would require careful evaluation of both
the number of beds, and probably more importantly,
throughput of those beds, and may require targeted
reallocation of beds. However, this will be a problem
facing late adopters; early adopters of guided transfer
should still have substantial opportunities to improve
their patients’ outcomes. All of the obstacles in Table 3
can be overcome to some extent.
Conclusion
Our contention is that physicians can and should hold
themselves accountable for the quality of care at the
hospitals to which they transfer patients. This is an issue
of professional excellence just as assuredly as giving
appropriate discharge prescriptions and insuring access
to follow-up care. The destination and timeliness of
transfers can be considered a target for ongoing quality
improvement. (Timeliness has been well reviewed by
others [59], including recent linking of rapidity of transfer
to outcomes [60!].) The predictable psychosocial chal-
lenges of transfer can be anticipated and mitigated [58].
Insuring that a critically ill patient gets to the best facility
seems tenable as a measure of quality suitable for rigorous
self-assessment at the level of the referring physician and
referring hospital. Although individual HospitalCompare
ratings often lack the precision necessary to dictate
which hospital is best for any given patient, physicians
can incorporate these into their own rich experiential
evidence on quality of care. The data suggest that guiding
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Table 3 Potential barriers to guided transfer
Potential barrier Explanation Evaluation
Habits Existing transfer patterns are engrained habits
and are often easier than getting the data and
making a guided transfer
If published estimates of the potential mortality benefits
are correct, there is substantial potential benefit
worth the extra time [8!]
Interest in outcomes other
than 30-day mortality
Prevention of 30-day mortality is not the only
goal of care for patients
This is as true for guided transfer as for the evaluation of
most therapies, for which RCT-evidence is available for
only a subset of valued outcomes. Where data are
available (e.g., CHF readmission rates), that can be
used. Elsewhere, reasoned clinical extrapolation is
necessary; is hospital quality on the values outcome
likely to be inversely correlated with quality on
the measured outcomes? Additional research should
make other measures publicly reported
Applicability to other patients Existing quality metrics often only evaluate
a subset of patients. What should be
done with patients outside of those metrics?
This is an important problem on which too little research
has been done; for now, clinical judgment is required
in extrapolation here as in many other clinical decisions
Capacity constraints at
best referring hospitals
Wouldn’t sending all these patients to the place
where they can get the best care overwhelm
those hospitals, and degrade the quality of
care they can provide?
Transfers for patients with clear critical illness should be
given precedence over patients admitted to the ICU for
observation [51!]. Modeling suggests that there may be
adequate resources for the truly critically ill [52], and
that high quality centers are able to maintain quality
even when operating at unusually high patient volumes
[53]. Moreover, it seems plausible that receiving
hospitals may have better information about their
capacity at any given moment than potential sending
hospitals, and so receiving hospitals can make these
triage decisions
Distinguishing hospitals
that are ‘not significantly
different’
Existing quality metrics have large standard
errors, and so often nearby hospitals are not
significantly different from each other
Even if hospitals are not different enough to reach a
standard of proof of difference suitable for policy use
at penalizing a hospital, patients will still do better
on average if consistently transferred to hospitals
with better outcome measures [54]
Patient preferences Patients may be skeptical of any transfer, or
not wish to go to the designated center
[55,56]
Current transfer decisions may put very little weight on
patient preferences, [30!] so any consideration may
be an improvement. Careful patient counseling should
focus on the magnitude of the potential mortality
benefit that could be achieved [57,58]
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transfers to consciously chosen hospitals could offer palp-
able, direct benefits for patients.
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